Product Recalls in Mississippi

Product recalls affecting Mississippi — including food, drugs, consumer products, medical devices, and vehicles distributed to Mississippi. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,641 recalls have been distributed to Mississippi in the last 12 months.

49,744 total recalls
2,641 in last 12 months

Showing 49214940 of 13,570 recalls

DrugDecember 20, 2019· Assurance Infusion

Recalled Item: SUFENTANIL 300MCG/ML INJ in 20 mL syringe Assurance Infusion (713)-533-8800...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 2.5MG/FENT 25MCG/HYDRO 2MG/MORP 40MG/ML in 20 mL syringe Assurance...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 35MG/FENT 1.5MG/ML in 20 mL syringe Assurance Infusion (713) 533-8800...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: TRIMIX (UA) 30MG/1MG/20MCG/ML INJ in 1 mL vial Assurance Infusion Recalled...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: TESTOSTERONE CYP 200MG/ML OIL (SESAME) INJ in 10 mL vial Recalled by...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BUP 15MG/CLON 300MCG/ FENT 1500MCG/ML(40) INJ in 20 mL syringe Recalled by...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: HYDROMORPHONE 3MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL vial Assurance Recalled by...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: HYDROMORPHONE 5MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: CLON 750MCG/MORP 30MG/SUF 37.5MCG/ML in 20 mL syringe Assurance Infusion...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BAC 225MCG/ BUP 4.5MG/ CLON 9MCG/ MORP 3MG/ML ML INJ Recalled by Assurance...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2019· Hikma Pharmaceuticals USA Inc.

Recalled Item: Ketorolac Tromethamine Injection Recalled by Hikma Pharmaceuticals USA Inc....

The Issue: Presence of Particulate Matter: particles identified as polydimethylsiloxane...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 17, 2019· Hikma Pharmaceuticals USA Inc.

Recalled Item: Ketorolac Tromethamine Injection Recalled by Hikma Pharmaceuticals USA Inc....

The Issue: Presence of Particulate Matter: particles identified as polydimethylsiloxane...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 16, 2019· Pharmedium Services, LLC

Recalled Item: NORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Recalled by...

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 16, 2019· Pharmedium Services, LLC

Recalled Item: NORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Recalled by...

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 16, 2019· Akorn Inc

Recalled Item: Hydrocortisone and Acetic Acid Otic Solution Recalled by Akorn Inc Due to...

The Issue: Subpotent Drug: Low Out of specification (OOS) assay results for the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 16, 2019· Pharmedium Services, LLC

Recalled Item: NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Recalled by...

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 13, 2019· The Harvard Drug Group

Recalled Item: Memantine Hydrochloride Extended-release Capsules Recalled by The Harvard...

The Issue: Failed Dissolution Specifications: High out of specification result observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 13, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Bimatoprost Ophthalmic Solution Recalled by Lupin Pharmaceuticals Inc. Due...

The Issue: Failed Impurities/Degradation Specifications: Out-of-specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 11, 2019· Spectrum Laboratory Products

Recalled Item: Estriol [(16a Recalled by Spectrum Laboratory Products Due to Subpotent...

The Issue: Subpotent Drug: Supplier indicated assay results did not meet specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund